New study tests ROSE program to stop postpartum depression before it starts

NCT ID NCT04940585

Recruiting now Prevention Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a program called ROSE, which includes six group sessions and one individual session for pregnant women. The goal is to see if it can prevent postpartum depression, reduce stress, and increase social support. About 308 pregnant women receiving care at a specific clinic will take part. The program covers topics like adjusting to life with a baby, effective communication, and planning for the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ROSE program (a series of 6 group sessions plus an individual session focused on psychoeducation, communication, and planning)
What this could lead to: If it works, this could provide an effective, scalable way to prevent postpartum depression in at-risk pregnant women.
What could go wrong: This is a relatively small, single-site study testing a behavioral intervention, so results may not apply broadly. The program may not significantly reduce depression compared to usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST PARTUM DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

postpartum depression prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST PARTUM DEPRESSION

Contacts and locations

Locations

NYU Langone Health
RECRUITING

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.